New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding

Xavier Calvet

doi:10.1016/S0210-5705(10)70003-0

New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding

Xavier Calvet

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Gastric pH should be maintained at very high values to prevent peptic ulcer rebleeding. A recent randomized trial, however, has confirmed that intravenous infusion of esomeprazole decreases the rebleeding rate after endoscopic therapy. In addition, the use of proton pump inhibitor perfusion at admission before diagnostic endoscopy reduces the need for endoscopic therapy and shortens the mean length of hospital stay. © 2010 Elsevier España S.L.

Original language	English
Pages (from-to)	11-14
Journal	Gastroenterologia y Hepatologia
Volume	33
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/S0210-5705(10)70003-0
Publication status	Published - 1 Jan 2010

Keywords

Endoscopic treatment
Esomeprazole
Peptic ulcer hemorrhage
Proton pump inhibitor

Access to Document

10.1016/S0210-5705(10)70003-0

Fingerprint Dive into the research topics of 'New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding'. Together they form a unique fingerprint.

Cite this

@article{e5363f74118e4541971888b851ed0102,

title = "New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding",

abstract = "Gastric pH should be maintained at very high values to prevent peptic ulcer rebleeding. A recent randomized trial, however, has confirmed that intravenous infusion of esomeprazole decreases the rebleeding rate after endoscopic therapy. In addition, the use of proton pump inhibitor perfusion at admission before diagnostic endoscopy reduces the need for endoscopic therapy and shortens the mean length of hospital stay. {\textcopyright} 2010 Elsevier Espa{\~n}a S.L.",

keywords = "Endoscopic treatment, Esomeprazole, Peptic ulcer hemorrhage, Proton pump inhibitor",

author = "Xavier Calvet",

year = "2010",

month = jan,

day = "1",

doi = "10.1016/S0210-5705(10)70003-0",

language = "English",

volume = "33",

pages = "11--14",

journal = "Gastroenterologia y Hepatologia",

issn = "0210-5705",

publisher = "Ediciones Doyma, S.L.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding

AU - Calvet, Xavier

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Gastric pH should be maintained at very high values to prevent peptic ulcer rebleeding. A recent randomized trial, however, has confirmed that intravenous infusion of esomeprazole decreases the rebleeding rate after endoscopic therapy. In addition, the use of proton pump inhibitor perfusion at admission before diagnostic endoscopy reduces the need for endoscopic therapy and shortens the mean length of hospital stay. © 2010 Elsevier España S.L.

AB - Gastric pH should be maintained at very high values to prevent peptic ulcer rebleeding. A recent randomized trial, however, has confirmed that intravenous infusion of esomeprazole decreases the rebleeding rate after endoscopic therapy. In addition, the use of proton pump inhibitor perfusion at admission before diagnostic endoscopy reduces the need for endoscopic therapy and shortens the mean length of hospital stay. © 2010 Elsevier España S.L.

KW - Endoscopic treatment

KW - Esomeprazole

KW - Peptic ulcer hemorrhage

KW - Proton pump inhibitor

U2 - 10.1016/S0210-5705(10)70003-0

DO - 10.1016/S0210-5705(10)70003-0

M3 - Article

VL - 33

SP - 11

EP - 14

JO - Gastroenterologia y Hepatologia

JF - Gastroenterologia y Hepatologia

SN - 0210-5705

IS - SUPPL. 1

ER -